Fuggetta et al. evaluated the effect of topical application of a moisturizer containing polydatin to prevent skin rash in 34 patients with mutated non-small cell lung cancer (NSCLC) treated with the EGFR-TKi afatinib. Here, EGFR is linked to Skin rash.